论文部分内容阅读
目的:探讨补肾调经活血中药口服与灌肠联合应用治疗子宫内膜异位症痛经的临床疗效与价值。方法:选取2012年9月—2013年5月收治的50例子宫内膜异位症患者作为观察对象,随机分为西药组和结合组,每组各25例。西药组采用孕三烯酮进行治疗,结合组使用中药口服与灌肠结合治疗。比较两组患者治疗后总有效率,痛经评分以及其他不适症状改善情况。结果:3个月规范治疗后,结合组治疗有效率为88.0%,西药组治疗有效率为64.0%,两组比较差异具有显著性(P<0.05);两组治疗前后痛经积分无明显差异(P>0.05),治疗后,结合组痛经积分显著优于西药组(P<0.05);治疗前,两组不适症状发生人数比较无明显差异(P>0.05),治疗后,结合组不适症状发生人数显著少于西药组(P<0.05)。结论:补肾调经活血药口服结合中药灌肠治疗子宫内膜异位症痛经疗效显著,不良反应小,能够有效缓解疼痛,改善患者生活质量,治疗费用低,值得临床推广应用。
Objective: To investigate the clinical efficacy and value of tonifying kidney, regulating menstruation and promoting blood circulation in the treatment of endometriosis dysmenorrhea by oral administration combined with enema. Methods: Fifty patients with endometriosis admitted from September 2012 to May 2013 were randomly divided into western medicine group and combination group, with 25 cases in each group. Western medicine group used gestrinone treatment, combination group using traditional Chinese medicine oral enema treatment. The total effective rate, dysmenorrhea score and other symptoms of two groups were compared after treatment to improve the situation. Results: After three months of standard treatment, the effective rate of the combination therapy group was 88.0% and that of the western medicine group was 64.0%, the difference between the two groups was significant (P <0.05); there was no significant difference between the two groups P> 0.05). After treatment, the scores of dysmenorrhea in combination group were significantly better than those in western medicine group (P <0.05). Before treatment, there was no significant difference in the number of discomfort symptoms between the two groups (P> 0.05) The number of patients was significantly less than that of western medicine group (P <0.05). Conclusion: Bushenjiaojinghuoxue medicine combined with traditional Chinese medicine enema for the treatment of endometriosis dysmenorrhea has significant curative effect, small adverse reactions, can effectively relieve pain, improve the quality of life of patients, the treatment cost is low, worthy of clinical promotion and application.